Stocks and Investing Stocks and Investing
Fri, November 4, 2022

Joseph Schwartz Maintained (AUPH) at Buy with Decreased Target to $12 on, Nov 4th, 2022


Published on 2024-10-27 23:56:33 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $17 to $12 on, Nov 4th, 2022.

Joseph has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, August 9th, 2022
Contributing Sources